It is a pharma private limited company based in Andhra Pradesh, Telangana, India, established in 2003.
2003 | Andhra Pradesh, Telangana, India | Under LiquidationEpr Pharmaceuticals Private Limited, a under liquidation private limited company, was established on 30 April 2003 in Andhra Pradesh, Telangana, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U24239TG2003PTC040924. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹15.50 Cr and a paid-up capital of ₹4.00 Cr.
Its leadership includes Sirigireddy Reddy (Additional Director), Onteddu Devi Nirmala (Director), Markandeya Gorantla (Additional Director). Past directors included Comandur Parthasarathy, Swaminatha Reddy Onteddu. It holds no open charges and ₹2.70 Cr settled loans. Its latest AGM occurred on 30 September 2014, with the balance sheet filed on 31 March 2014. It is based at Plot No.557, Road No.31,Jubilee Hills, Hyderabad-33., Andhra Pradesh, Telangana, 500033.
U24239TG2003PTC040924
040924
30 April 2003
₹15.50 Cr
₹4.00 Cr
Roc Hyderabad
Unlisted
Under Liquidation
Explore comprehensive insights into Epr Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sirigireddy Reddy | Additional Director | 10 Jul 2015 | Current |
| Onteddu Devi Nirmala | Director | 30 Apr 2003 | Current |
| Markandeya Gorantla | Additional Director | 10 Jul 2015 | Current |
| Premkumar Eragam Reddy | Director | 04 Nov 2003 | Current |
| Prashanth Eragam Reddy | Director | 24 Aug 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Sep 2011 | Past |
| Pramod Abcsdd | Director | 30 Mar 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Epr Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Epr Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹27,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Oct 2011 | Karvy Financial Services Limited | ₹2.70 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Epr Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Epr Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epr Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sirigireddy Reddy was appointed as a Additional Director was appointed as a Additional Director on 10 Jul 2015 & has been associated with this company since 10 years 4 months . was documented.
Markandeya Gorantla was appointed as a Additional Director was appointed as a Additional Director on 10 Jul 2015 & has been associated with this company since 10 years 4 months . was recorded as a recent event.
Progress on Epr Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2014 as per latest MCA records. was documented.
A charge registered on 03 Oct 2011 via Charge ID 10319904 with Karvy Financial Services Limited was fully satisfied on 20 Aug 2014. was recorded as a recent event.
Progress on Epr Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Hyderabad. was documented.
Progress on A charge with Karvy Financial Services Limited amounted to Rs. 2.70 Cr with Charge ID 10319904 was registered on 03 Oct 2011. was documented.
The CIN of Epr Pharmaceuticals Private Limited is U24239TG2003PTC040924.
Epr Pharmaceuticals Private Limited is headquartered at Plot No.557, Road No.31,Jubilee Hills, Hyderabad-33., Andhra Pradesh, Telangana, 500033.
Epr Pharmaceuticals Private Limited was incorporated on 30 April 2003.
The current directors of Epr Pharmaceuticals Private Limited are
The primary industry of Epr Pharmaceuticals Private Limited is Pharma.
Epr Pharmaceuticals Private Limited is unlisted.
The authorized capital of Epr Pharmaceuticals Private Limited is ₹15.50 Cr, and the paid-up capital is ₹4.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX